(Q36383799)

13 August 2017

1 reference

title

Extraintestinal isolates of Escherichia coli: identification and prospects for vaccine development (English)

1 reference

13 August 2017

0 references

2

James R Johnson

1 reference

13 August 2017

Thomas A Russo

1

1 reference

13 August 2017

publication date

1 February 2006

1 reference

Expert Review of Vaccines

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

45-54

1 reference

Efficacy and safety of recombinant human activated protein C for severe sepsis

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Burden of community-onset Escherichia coli bacteremia in seniors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Escherichia coli bacteraemia in patients with and without haematological malignancies: a study of strain characters and recurrent episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Recurrent Escherichia coli bacteraemia--clinical characteristics and bacterial properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Resolution time of Escherichia coli cystitis is correlated with levels of preinfection antibody to the infecting Escherichia coli strain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Protective Efficacy of Pneumococcal Polysaccharide Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Bacterial polysaccharides in sickness and in health. The 1995 Fleming Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Synthetic peptides corresponding to protective epitopes of Escherichia coli digalactoside-binding pilin prevent infection in a murine pyelonephritis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Immunization with the binding domain of FimH, the adhesin of type 1 fimbriae, does not protect chickens against avian pathogenic Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Dra/AfaE adhesin of uropathogenic Dr/Afa+ Escherichia coli mediates mortality in pregnant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Transcriptome of uropathogenic Escherichia coli during urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Identification of pathogen-specific and conserved genes expressed in vivo by an avian pathogenic Escherichia coli strain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

The siderophore receptor IroN, but not the high-pathogenicity island or the hemin receptor ChuA, contributes to the bacteremic step of Escherichia coli neonatal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Molecular epidemiological and phylogenetic associations of two novel putative virulence genes, iha and iroN(E. coli), among Escherichia coli isolates from patients with urosepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Phylogenetic and pathotypic similarities between Escherichia coli isolates from urinary tract infections in dogs and extraintestinal infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Systemic and mucosal antibody responses to selected cell surface antigens of avian pathogenic Escherichia coli in experimentally infected chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Identification of a new iron-regulated virulence gene, ireA, in an extraintestinal pathogenic isolate of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Protection by a polyvalent vaccine against challenge infection and pyelonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Experimental investigations on the immunomodulating activity of polybacterial preparation for peroral immunotherapy and immunoprophylaxis of uroinfections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Molecular comparison of extraintestinal Escherichia coli isolates of the same electrophoretic lineages from humans and domestic animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Antimicrobial-resistant and extraintestinal pathogenic Escherichia coli in retail foods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Generation of isogenic K54 capsule-deficient Escherichia coli strains through TnphoA-mediated gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Extraintestinal pathogenic Escherichia coli: "the other bad E coli".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Humoral immune responses to microbial infections in the genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Influence of the age and sex of human hosts on the distribution of Escherichia coli ECOR groups and virulence traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

Molecular Epidemiology of 3 Putative Virulence Genes forEscherichia coliUrinary Tract Infection—usp, iha,andiroNE. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.45

21 January 2018

Identifiers

DOI

10.1586/14760584.5.1.45

1 reference

13 August 2017

1 reference